Purpose In rodents, a single exercise bout performed 24 h prior to a single doxorubicin
treatment provides cardio-protection. This study investigated whether performing this …

Background Preclinical studies have reported that a single treadmill session performed 24 h
prior to doxorubicin provides cardio-protection. We aimed to characterize the acute change …

Asymptomatic cardiotoxicity following breast cancer treatment is a significant issue for many
patients, as these patients typically face an increased risk of cardiovascular disease (CVD) …

Women diagnosed with breast cancer typically undergo a multimodal approach to treating
their disease. The treatments used often result in sequelae such as fatigue, hair loss …

Introduction Preclinical data demonstrate the potential for exercise training to protect against
anthracycline-related cardiotoxicity, but this remains to be shown in humans. Purpose To …

Background Anthracycline chemotherapy may be associated with decreased cardiac
function and functional capacity measured as the peak oxygen uptake during exercise (V· O …

Anthracycline-containing chemotherapy (eg, doxorubi-cin) is well known to cause dose-
dependent, progressive cardiac damage clinically manifest as decreased left ventricular …

Conventional resting left ventricular ejection fraction (LVEF) assessments have limitations
for detecting doxorubicin (DOX)-related cardiac dysfunction. Novel resting …

Objective Therapeutic exercise is already used to ameliorate some of the side effects of
cancer treatment. Recent studies examined its preventive potential regarding treatment …

Aims Exercise training has been suggested to prevent anthracycline-related cardiac
dysfunction, but clinicalbased evidence is scarce. We investigated the effects of a …